Treatment of erosive osteoarthritis with peroxisome proliferator-activated receptor alpha agonist fenofibrate: a pilot study
Abstract
Hand osteoarthritis (HOA) is a common condition associated with high disease burden and frequently accompanied by comorbidities including dyslipidemia, atherosclerosis and obesity. The most debilitating HOA phenotype is erosive HOA (EHOA), characterized by synovial inflammation, formation of erosions, and substantial decline in hand function. Currently, there is no proven symptomatic treatment for the EHOA. Due to their broad spectrum effects directed on lipid metabolism, inflammation and pain, the agonists of peroxisome proliferator-activated receptor alpha or fibrates are a candidate class of drugs for the treatment of EHOA. In this study, we assessed the influence of fenofibrate treatment on clinical efficacy parameters, in vivo cytokine and adipokine production and concentrations of endothelial progenitor cells (EPC) in patients with EHOA. Fourteen patients received treatment with 145 mg of fenofibrate/day for 12 weeks. Fenofibrate treatment was associated with significant decreases in pain score, tender joint count, duration of morning stiffness, disease activity score, Cochin index, and ESR. Eight (57.14 %) patients developed Outcome Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society response at the end of treatment. Paracetamol consumption did not change during the treatment course. There was a significant reduction in triglyceride levels. No changes were detected in serum pro-inflammatory cytokine and adipokine concentrations while circulating IL-10 levels significantly decreased. There were no differences in circulating EPC numbers before and after the treatment. Fenofibrate was well tolerated, no patient experienced disease flare during the treatment. In conclusion, in EHOA patients, fenofibrate is associated with pleiotropic effects on pain, inflammation, and lipid profile. Larger, controlled studies are needed to confirm these results.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In an open label study on patients with erosive hand OA, FN use for 12 weeks was associated with significant improvements in the Cochin hand functional disability scale.
“These findings are in line with an open label study performed on patients with erosive hand OA where FN use for 12 weeks was associated with significant improvements in the Cochin hand functional disability scale [61].”
From Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy (2019) · cites this paper as [61]
Cites
Altman, R. D., Alarcón, G. S., Appelrouth, D. J., Bloch, D. A., BORENSTEIN, D. G., Brandt, K. D., Brown, C., Cooke, T. D. V., Daniel, W., Feldman, D. P., et al. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340502 · Cited by 2,631 · see citing works
Altman, R. D., Alarcón, G. S., Appelrouth, D. J., Bloch, D. A., BORENSTEIN, D. G., Brandt, K. D., Brown, C., Cooke, T. D. V., Daniel, W., Gray, R., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331101 · Cited by 1,130 · see citing works
Pham, T., van der Heijde, D. M. F. M., Altman, R. D., Anderson, J. J., Bellamy, N., Hochberg, M. C., Simon, L. S., Strand, V., Woodworth, T., & Dougados, M. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.02.001 · Cited by 849 · see citing works
Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α
LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A., & Piomelli, D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111385 · Cited by 316 · see citing works
Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?
Dimmeler, S., & Zeiher, A. M. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0580-x · Cited by 294 · see citing works
Lipid metabolism and osteoarthritis: Lessons from atherosclerosis
Gkretsi, V., Simopoulou, T., & Tsezou, A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.11.001 · Cited by 186 · see citing works
Botter, S. M., van Osch, G. J. V. M., Clockaerts, S., Waarsing, J. H., Weinans, H., & van Leeuwen, J. P. T. M. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30307 · Cited by 168 · see citing works
Belfort, R., Berria, R., Cornell, J. E., & Cusi, K. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1487 · Cited by 159 · see citing works
Poiraudeau, S., Chevalier, X., Conrozier, T., Flippo, R.-M., Lioté, F., Noël, É., Lefèvre‐Colau, M., Fermanian, J., Revel, M., & Rhumato, R. (2001) · Osteoarthritis and Cartilage · doi:10.1053/joca.2001.0422 · Cited by 138 · see citing works
Cascão, R., Moura, R. A., Perpetuo, I. P., Canhão, H. M., Vieira‐Sousa, E., Mourão, A. F., Rodrigues, A. M., Pereira, J. P., Queiroz, M. V., Rosario, H., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3168 · Cited by 122 · see citing works
Kwok, W., Kloppenburg, M., Rosendaal, F. R., van Meurs, J. B. J., Albert Hofman, D., & Bierma‐Zeinstra, S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143016 · Cited by 98 · see citing works
de Oliveira, A. C. P., Bertollo, C. M., Rocha, L. T. S., Junior, E. B. D. N., Costa, K. A., & Coelho, M. M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.026 · Cited by 78 · see citing works
Clinical burden of erosive hand osteoarthritis and its relationship to nodes
Bijsterbosch, J., Watt, I., Meulenbelt, I., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.125435 · Cited by 76 · see citing works
Stunes, A. K., Westbroek, I., Gustafsson, B. I., Fossmark, R., Waarsing, J. H., Eriksen, E. F., Petzold, C., Reseland, J. E., & Syversen, U. (2011) · BMC Endocrine Disorders · doi:10.1186/1472-6823-11-11 · Cited by 75 · see citing works
Tarek, B., Tual‐Chalot, S., Andriantsitohaina, R., & Martínez, M. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012392 · Cited by 56 · see citing works
Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study
Saviola, G., Abdì-Alì, L., Campostrini, L., Sacco, S., Baiardi, P., Manfredi, M., Mannoni, A., & Benucci, M. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0506-8 · Cited by 45 · see citing works
Ward, M. M. (2004) · PubMed · Cited by 43 · see citing works
François, M., Richette, P., Tsagris, L., Fitting, C., May, C. L., Benallaoua, M., Tahiri, K., & Corvol, M. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21728 · Cited by 43 · see citing works
Redondo, S., Hristov, M., Gordillo‐Moscoso, A., Ruiz, E., Weber, C., & Tejerina, T. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.02.011 · Cited by 31 · see citing works
Erosive osteoarthritis: a current review of a clinical challenge
Banks, S. E. (2010) · Clinical Rheumatology · doi:10.1007/s10067-009-1369-7 · Cited by 31 · see citing works
Goto, M. (2010) · Modern Rheumatology · doi:10.1007/s10165-009-0261-2 · Cited by 29 · see citing works
Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study
Saviola, G., Abdì-Alì, L., Campostrini, L., et al. (2012) · Modern Rheumatology · doi:10.3109/s10165-011-0506-8 · Cited by 29 · see citing works
Goto, M. (2010) · Modern Rheumatology · doi:10.3109/s10165-009-0261-2 · Cited by 20 · see citing works
Shirinsky, I. V., & Shirinsky, V. S. (2011) · International Journal of Rheumatology · doi:10.1155/2011/937843 · Cited by 18 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy
Nogueira-Recalde, U., Lorenzo-Gómez, I., Blanco, F. J., Loza, M. I., Grassi, D., Shirinsky, V., Shirinsky, I., Lotz, M., Robbins, P. D., Domínguez, E., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.049 · Cited by 155 · see citing works
Self-citation
- Authors
- Shirinsky, I. V., & Shirinsky, V. S.
- Affiliations
- Research Institute of Fundamental and Clinical Immunology (RU)
- Corresponding author
- Shirinsky, Ivan V.
- Venue
- Rheumatology International
- Published
- 2013-04-26
- Volume
- 34
- Issue
- 5
- Pages
- 613-616
- ISSN
- 0172-8172 (ISSN-L)
- 1437-160X
- OpenAlex
- W2067148732
- Cited by
- 22
- References
- 24
- Citations by year
- 2026: 1 · 2025: 4 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2013: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Rheumatology International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Hypertrophic osteoarthropathy and related conditions
- Keywords
- erosive osteoarthritis, hand osteoarthritis, fenofibrate, fibrates, triglyceride lowering, IL-10, inflammatory cytokines, adipokines, endothelial progenitor cells, pain, synovitis, disease activity
- MeSH terms
- Anti-Inflammatory Agents, Female, Humans, Middle Aged, Osteoarthritis, Pilot Projects, Fenofibrate, Time Factors, Biomarkers, Treatment Outcome, Analgesics, Non-Narcotic, Inflammation Mediators, Recovery of Function, PPAR alpha, Hand Joints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
